An equally compelling finding of this study is the identification of TPP as an effective P2Y6 receptor antagonist for the treatment of atherosclerosis. Using a high-throughput Glide docking pipeline for drug repurposing, the authors screened existing drug libraries and discovered TPP’s potential. This evidence concerns the gene P2RY6 and atherosclerosis.